Literature DB >> 27495928

Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement.

Gabriel Liberale1, Michel El Houkayem2, Claire Viste2, Fikri Bouazza2, Michel Moreau3, Issam El Nakadi2, Isabelle Veys4.   

Abstract

PURPOSE: Totally implantable vascular access devices (TIVADs) are widely used to administer chemotherapy to cancer patients. While great progress has been made with respect to breast surgical reconstruction to take into account both aesthetics and patients' perceptions of body integrity, these aspects have not been considered with regard to the impact of TIVAD. In order to address this practice gap, we have adapted our TIVAD implantation technique to improve cosmetic results. The aim of this study was to assess breast cancer patients' comfort level and aesthetic satisfaction with regard to TIVAD insertion.
METHODS: Patients with breast cancer admitted for chemotherapy at an outpatient clinic completed a previously validated survey evaluating three main domains: symptoms (pain, discomfort) related to the TIVAD itself in daily activity, information received before and during the surgical procedure, and cosmetic aspects regarding the port insertion site (scar, port, and catheter location).
RESULTS: Between September 2010 and June 2011, 232 patients were evaluated. Cosmetic satisfaction with scar location was high (93.3 %). Information given to patients before and during the procedure had a major impact on both symptom perception in daily activity and on cosmetic satisfaction.
CONCLUSIONS: Obtaining a more aesthetic scar by placing the TIVAD in the deltopectoral groove contributed to a high rate of cosmetic satisfaction. Furthermore, the relevance of information given to patients before and/or during surgery had a major impact on symptom perception. Therefore, we suggest including a pre-operative information session in the care pathway.

Entities:  

Keywords:  Breast cancer; Cosmetic satisfaction; QoL; TIVAD

Mesh:

Year:  2016        PMID: 27495928     DOI: 10.1007/s00520-016-3368-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  8 in total

Review 1.  Update on totally implantable venous access devices.

Authors:  Ahmad Zaghal; Mohamed Khalife; Deborah Mukherji; Nadim El Majzoub; Ali Shamseddine; Jamal Hoballah; Gabriele Marangoni; Walid Faraj
Journal:  Surg Oncol       Date:  2012-03-17       Impact factor: 3.279

Review 2.  Systematic review and meta-analysis of percutaneous subclavian vein puncture versus surgical venous cutdown for the insertion of a totally implantable venous access device.

Authors:  L A Orci; R P H Meier; P Morel; W Staszewicz; C Toso
Journal:  Br J Surg       Date:  2013-11-26       Impact factor: 6.939

3.  Evaluation of three different techniques for insertion of totally implantable venous access device: A randomized clinical trial.

Authors:  Ana Paula Tagliari; Fernanda Luiza Staub; José Ricardo Guimarães; Alceu Migliavacca; Diego da Fonseca Mossmann
Journal:  J Surg Oncol       Date:  2015-07-14       Impact factor: 3.454

4.  Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies.

Authors:  H Kreis; C R Loehberg; M P Lux; S Ackermann; W Lang; M W Beckmann; P A Fasching
Journal:  Eur J Surg Oncol       Date:  2006-10-09       Impact factor: 4.424

5.  No impact of central venous insertion site on oncology patients' quality of life and psychological distress. A randomized three-arm trial.

Authors:  Roberto Biffi; Franco Orsi; Simonetta Pozzi; Andrea Maldifassi; Davide Radice; Nicole Rotmensz; Maria Giulia Zampino; Nicola Fazio; Giulia Peruzzotti; Florence Didier
Journal:  Support Care Cancer       Date:  2010-08-28       Impact factor: 3.603

6.  Effect of cosmetic outcome on quality of life after breast cancer surgery.

Authors:  M K Kim; T Kim; H G Moon; U S Jin; K Kim; J Kim; J W Lee; J Kim; E Lee; T K Yoo; D-Y Noh; K W Minn; W Han
Journal:  Eur J Surg Oncol       Date:  2014-12-19       Impact factor: 4.424

7.  Totally implantable venous access ports--the patients' point of view. A quality control study.

Authors:  C G Borst; A T de Kruif; F S van Dam; P W de Graaf
Journal:  Cancer Nurs       Date:  1992-10       Impact factor: 2.592

8.  Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.

Authors:  Kul Ranjan Singh; Gaurav Agarwal; Gitika Nanda; Gyan Chand; Anjali Mishra; Amit Agarwal; Ashok K Verma; Saroj K Mishra; Puneet Goyal
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

  8 in total
  3 in total

1.  Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)?

Authors:  Tian-Tian Tang; Lei Liu; Chun-Xiao Li; Yun-Tao Li; Tao Zhou; Hai-Ping Li; Jianxin Wang
Journal:  World J Surg       Date:  2019-09       Impact factor: 3.352

Review 2.  Adult oncology patients' experiences of living with a central venous catheter: a systematic review and meta-synthesis.

Authors:  Dhurata Ivziku; Raffaella Gualandi; Francesca Pesce; Anna De Benedictis; Daniela Tartaglini
Journal:  Support Care Cancer       Date:  2022-01-14       Impact factor: 3.603

3.  Tailored approach to the choice of long-term vascular access in breast cancer patients.

Authors:  Hyangkyoung Kim; Sukyung Kwon; Soo Mi Son; Eunseon Jeong; Jang-Yong Kim
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.